Literature DB >> 28446822

Anti-Mycobacterium activity of microbial peptides in a silkworm infection model with Mycobacterium smegmatis.

Akiho Yagi1, Ryuji Uchida1, Hiroshi Hamamoto2, Kazuhisa Sekimizu2, Ken-Ichi Kimura3, Hiroshi Tomoda1.   

Abstract

An in vivo-mimic silkworm infection model with Mycobacterium smegmatis was established. When silkworms were raised at 37 °C following an injection of M. smegmatis cells (1.25 × 107 CFU larva-1 g-1) into the silkworm hemolymph, they died within 48 h. Under these conditions, four microbial peptides with anti-M. smegmatis activity, lariatin A, calpinactam, lysocin E and propeptin, exerted therapeutic effects in a dose-dependent manner, and these are also clinically used agents that are active against Mycobacterium tuberculosis. These results indicate that the silkworm infection model with M. smegmatis is practically useful for the screening of therapeutically effective anti-M. tuberculosis antibiotics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28446822     DOI: 10.1038/ja.2017.23

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

1.  A novel diterpene agent isolated from Microbispora hainanensis strain CSR-4 and its in vitro and in silico inhibition effects on acetylcholine esterase enzyme.

Authors:  Chitti Thawai; Nantiya Bunbamrung; Pattama Pittayakhajonwut; Sumet Chongruchiroj; Jaturong Pratuangdejkul; Ya-Wen He; Sarin Tadtong; Vipaporn Sareedenchai; Pinidphon Prombutara; Yang Qian
Journal:  Sci Rep       Date:  2020-07-06       Impact factor: 4.379

Review 2.  Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis.

Authors:  Erik J Hasenoehrl; Thomas J Wiggins; Michael Berney
Journal:  Front Cell Infect Microbiol       Date:  2021-01-11       Impact factor: 5.293

Review 3.  Animal infection models using non-mammals.

Authors:  Chikara Kaito; Kanade Murakami; Lina Imai; Kazuyuki Furuta
Journal:  Microbiol Immunol       Date:  2020-08-22       Impact factor: 1.955

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.